Trial intelligence / Profile preview

Ferrlecit in anemic cancer patients

NCT00224068Phase 4Completed

Sponsor
Watson Pharmaceuticals
Start
May 2002
Primary completion
Dec 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sodium ferric gluconate in anemia, sponsored by Watson Pharmaceuticals. Started May 2002; status: completed.

02

Drugs

sodium ferric gluconate
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00224068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00224068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call